MktsMarkets

Trevi Therapeutics, Inc.
NASDAQ: TRVIKey statistics
TRVI News
Stories mentioning TRVI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 9,941 | 6,193 | 10,085 | 9,389 | 7,811 | 9,328 | 11,224 | 10,021 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 14,912 | 10,220 | 13,916 | 13,722 | 11,470 | 12,242 | 14,087 | 13,289 |
| Operating Income (Loss) | (14,912) | (10,220) | (13,916) | (13,722) | (11,470) | (12,242) | (14,087) | (13,289) |
| Interest Income | 1,696 | 1,903 | 2,101 | 1,407 | 1,125 | 843.00 | 826.00 | 935.00 |
| Interest Expense | 1.00 | |||||||
| Other Expense | 4.00 | (16.00) | (2.00) | (7.00) | (6.00) | 2.00 | (11.00) | (5.00) |
| Pretax Income | (13,212) | (8,333) | (11,817) | (12,322) | (10,351) | (11,398) | (13,273) | (12,360) |
| Tax Provision | (20.00) | (17.00) | (15.00) | (21.00) | (11.00) | 17.00 | (31.00) | (8.00) |
| Net Income (Loss) | (13,192) | (8,316) | (11,802) | (12,301) | (10,340) | (11,415) | (13,242) | (12,352) |
| Earnings Per Share (Basic) | (0.09) | (0.06) | (0.08) | (0.09) | (0.09) | (0.11) | (0.13) | (0.12) |
| Earnings Per Share (Diluted) | (0.09) | (0.06) | (0.08) | (0.09) | (0.09) | (0.11) | (0.13) | (0.12) |
| Weighted Average Shares Outstanding (Basic) | 145,593 | 134,747 | 145,105 | 130,350 | 117,611 | 101,972 | 101,282 | 101,042 |
| Weighted Average Shares Outstanding (Diluted) | 145,593 | 134,747 | 145,105 | 130,350 | 117,611 | 101,972 | 101,282 | 101,042 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TRVI
Trevi Therapeutics, Inc. (NASDAQ: TRVI) is a stock listed on the Nasdaq Stock Market under the ticker symbol TRVI. It last traded at $11.88 (Oct 16, 2026, 4:00 PM ET), down 1.9% on the day. That gives Trevi Therapeutics a market capitalisation of $1.7B.
Over the past 52 weeks TRVI has traded between $9.82 and $20.22.
For the quarter ended Mar 31, 2026 it reported a net loss of $13.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$13.2M |
| Dec 31, 2025 | — | -$8.3M |
| Sep 30, 2025 | — | -$11.8M |
| Jun 30, 2025 | — | -$12.3M |
From Trevi Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…